Bioharvest Sciences (BHST) Enterprise Value (2023 - 2025)

Bioharvest Sciences' Enterprise Value history runs 3 years deep, the most recent figure standing at -$23.0 million for Q4 2025.

• On a quarterly basis, Enterprise Value fell 733.94% year-over-year to -$23.0 million in Q4 2025; TTM through Dec 2025 was -$23.0 million, a 733.94% decrease from a year earlier, with the FY2025 full-year figure at -$23.0 million, down 733.94% from the prior year.
• Enterprise Value declined to -$23.0 million in Q4 2025 per BHST's latest filing, from -$11.4 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$2.8 million in Q1 2024 and bottomed at -$23.0 million in Q4 2025.
• The 3-year median for Enterprise Value is -$4.1 million (2025), against an average of -$6.9 million.
• Across the five-year window, Enterprise Value soared 50.11% in 2024 and slumped 733.94% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$5.5 million in 2023, then soared by 50.11% to -$2.8 million in 2024, then plunged by 733.94% to -$23.0 million in 2025.
• Per Business Quant, the three latest BHST Enterprise Value figures stand at -$23.0 million (Q4 2025), -$11.4 million (Q3 2025), and -$4.1 million (Q2 2025).